InChi: InChI=1S/C44H49N13O7/c1-26-32-23-47-44(50-39(32)56(29-6-3-4-7-29)42(62)37(26)27(2)58)48-35-12-10-30(22-46-35)54-17-15-53(16-18-54)24-28-25-55(52-51-28)19-21-64-20-14-45-33-9-5-8-31-38(33)43(63)57(41(31)61)34-11-13-36(59)49-40(34)60/h5
which comprises TD-106 linked to a BET inhibitor
but not in ND or TR animals
inhibition of tumor cell division and the induction of tumor cell apoptosis
8 μM and 1
Ibutamoren mesylate - CAS# 159752-10-0 Size:Solid 10 mg InChi: InChI=1S/C44H49N13O7/c1-26-32-23-47-44(50-39(32)56(29-6-3-4-7-29)42(62)37(26)27(2)58)48-35-12-10-30(22-46-35)54-17-15-53(16-18-54)24-28-25-55(52-51-28)19-21-64-20-14-45-33-9-5-8-31-38(33)43(63)57(41(31)61)34-11-13-36(59)49-40(34)60/h5Ibutamoren, also known as MK 677, MK 0667, and L 163,191, is a non peptidic, potent, long acting, orally active, and selective agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH) stimulating action of the endogenous hormone ghrelin. It has been demonstrated to increase the release of, and produces sustained increases in plasma levels of several hormones including GH and insulin like growth factor 1 (IGF
